Article
Does Xpert® MTB/RIF assay give rifampicin resistance results without identified mutation? Review of cases from Addis Ababa, Ethiopia.
BMC infectious diseases - 30 Jan 2020
Alemu Ayinalem, Tadesse Mengistu, Seid Getachew, Mollalign Helina, Eshetu Kirubel, Sinshaw Waganeh, Abebaw Yeshiwork, Amare Misikir, Dagne Biniyam, Diriba Getu, Yenew Bazezew, Getu Melak, Zerihun Betselot
Abstract excerpt
BACKGROUND: Xpert® MTB/RIF assay is currently used in Ethiopia for the rapid diagnosis of Mycobacterium tuberculosis (MTB) and mutations that confer Rifampicin resistance. Rifampicin resistance is determined based on any mutation in the 81 bp of rpoB gene using five overlapping probes represented as Probe A (codons 507-511), Probe B (codons 512-518), Probe C (codons 518-523), Probe D (codons 523-529) and Probe E...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
